Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-089780
Filing Date
2026-08-03
Accepted
2026-08-03 16:01:11
Documents
1
Period of Report
2026-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2622051-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2622051-1_4seq1.xml 4 3360
  Complete submission text file 0001104659-26-089780.txt   4996
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Issuer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ZERNIKEDREEF 9 C/O PROQR THERAPEUTICS N.V. LEIDEN Netherlands 2333 CK
Business Address
de Boer Daniel Anton (Reporting) CIK: 0002117546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36622 | Film No.: 261232688